Thoratec Should Sever Link Between International And U.S. Websites FDA
This article was originally published in The Gray Sheet
Thoratec Laboratories Corp. disputes FDA's assertions in an Aug. 12 warning letter that the company misbranded its VAD device and inappropriately promoted its TLC-II portable VAD driver, which is currently under an approved investigational device exemption.
You may also be interested in...
Approval of a "bridge-to-transplant" indication for the BVS-5000 device has never been sought by the company, as was reported in "The Gray Sheet" (1Aug. 30, p. 11). The device is approved for temporary cardiac support for post-cardiotomy shock, cardiac transplant failure, myocarditis, and right-ventricular assist while the patient is on an implantable left ventricular assist device
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.